SERCA Inhibition Limits the Functional Effects of Cyclic GMP in Both Control and Hypertrophic Cardiac Myocytes

Publisher： Karger

E-ISSN： 1423-0313|83|4|223-230

ISSN： 0031-7012

Source： Pharmacology, Vol.83, Iss.4, 2009-03, pp. : 223-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreasing Cyclic GMP Exerts Similar Positive Functional Effects on Cardiac Myocytes Regardless of Initial Level

By  

Pharmacology, Vol. 61, Iss. 1, 2000-07 ,pp. : 51-56

Karger

Access to resources Recommend Favorite

Functional Interaction of a β-Adrenergic Agonist and Cyclic GMP Phosphodiesterase Inhibitor in Control and Hypertrophic Cardiomyocytes

By  

Pharmacology, Vol. 76, Iss. 2, 2006-01 ,pp. : 53-60

Karger

Access to resources Recommend Favorite

Cyclic GMP-Induced Reduction in Cardiac Myocyte Function Is Partially Mediated by Activation of the Sarcoplasmic Reticulum Ca2+-ATPase

By  

Pharmacology, Vol. 64, Iss. 2, 2002-01 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Ethanol Reduces Cardiac Myocyte Function through Activation of the Nitric Oxide-Cyclic GMP Pathway

By  

Pharmacology, Vol. 67, Iss. 2, 2003-01 ,pp. : 59-66

Karger

Access to resources Recommend Favorite

HDAC Inhibition Improves the Sarcoendoplasmic Reticulum Ca2+-ATPase Activity in Cardiac Myocytes

By Meraviglia Viviana   Bocchi Leonardo   Sacchetto Roberta   Florio Maria Cristina   Motta Benedetta M.   Corti Corrado   Weichenberger Christian X.   Savi Monia   D’Elia Yuri   Rosato-Siri Marcelo D.   Suffredini Silvia   Piubelli Chiara   Pompilio Giulio   Pramstaller Peter P.   Domingues Francisco S.   Stilli Donatella   Rossini Alessandra  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 419-419

MDPI

Access to resources Recommend Favorite